191 Publications (Page 6 of 8)
2010
Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Suvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifObryant, RobinObryant, RobinWood, Lisa lWood, Lisa lPorter, NicolePorter, NicoleAbonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 1970, 2010-11-19. | Journal Article
 
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
Wang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingSinn, AnthonySinn, Anthony LSinn, AnthonySinn, AnthonyPollok, KarenPollok, KarenPollok, KarenPollok, KarenSandusky, GeorgeSandusky, GeorgeSandusky, GeorgeSandusky, GeorgeZhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongChen, LiChen, LiChen, LiChen, LiLiang, JingLiang, JingLiang, JingLiang, JingCrean, Colin DCrean, ColinCrean, ColinCrean, ColinSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatSidor, CarolynSidor, CarolynSidor, CarolynSidor, CarolynBray, MarkBray, Mark RBray, MarkBray, MarkFarag, SherifFarag, SherifFarag, Sherif and Farag, Sherif S
British Journal of Haematology, vol. 150, (no. 3), pp. 313-325, 2010. | Journal Article
 
The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors
Homsi, YaserAlwan, DareenKiel, PatrickRosenbeck, LindsayShivani, SrivastavaSchwartz, Jennifer ENelson, Robert PAbonour, RafatRobertson, Michael and Farag, Sherif
Blood, vol. 116, (no. 21), pp. 2345, 2010-11-19. | Journal Article
2009
Adaptation of family caregivers during the acute phase of adult BMT.
Fife, BetsyMonahan, P OAbonour, RWood, L L and Stump, T E
Bone marrow transplantation, vol. 43, (no. 12), pp. 959-66, 2009/Jun. | Journal Article
 
A Phase I Safety Study of Enzastaurin Plus Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma
Ghobrial, Irene MMunshi, Nikhil CHarris, Brianna NYuan, ZhengPorter, Nichole MSchlossman, Robert LLaubach, Jacob PAnderson, Kenneth CLin, Courtney EWooldridge, James ERichardson, Paul G and Abonour, Rafat
Blood, vol. 114, (no. 22), pp. 1870, 2009-11-20. | Journal Article
 
A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
Farag, SherifWood, Lisa LSrivastava, ShivaniNelson, Robert PSchwartz, Jennifer ECox, ElizabethAbonour, Rafat and Robertson, Michael
Blood, vol. 114, (no. 22), pp. 3402, 2009-11-20. | Journal Article
 
Clinical value of minor responses after 4 doses of rituximab in Waldenstrom macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial
Gertz, MorieGertz, Morie AAbonour, RafatAbonour, RafatHeffner, LeonardHeffner, Leonard TGreipp, PhilipGreipp, Philip RUno, HajimeUno, HajimeRajkumar, S. and Rajkumar, S V
British Journal of Haematology, vol. 147, (no. 5), pp. 680, December 2009. | Journal Article
 
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Chen, ChristineChen, ChristineReece, DonnaReece, DonnaSiegel, DavidSiegel, DavidNiesvizky, RubenNiesvizky, RubenBoccia, RalphBoccia, Ralph VStadtmauer, Edward AStadtmauer, EdwardAbonour, RafatAbonour, RafatRichardson, PaulRichardson, Paul GMatous, JeffreyMatous, JeffreyKumar, Shaji KKumar, ShajiBahlis, Nizar JBahlis, NizarAlsina, MelissaAlsina, MelissaVescio, Robert AVescio, RobertCoutre, StevenCoutré, Steven EPietronigro, DennisPietronigro, DennisKnight, RobertKnight, Robert DZeldis, Jerome BZeldis, JeromeRajkumar, Vincent and Rajkumar, Vincent
British Journal of Haematology, vol. 146, (no. 2), pp. 170, July 2009. | Journal Article
 
Multiple Myeloma Derived Factors Generate Tolerogenic Dendritic Cells by Activation of STAT3: A Potential Target for Immunotherapy
Homsi, YaserHomsi, YaserHomsi, YaserChen, LiChen, LiChen, LiZhang, ShuhongZhang, ShuhongZhang, ShuhongLiang, JingLiang, JingLiang, JingSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatFarag, SherifFarag, Sherif and Farag, Sherif
Blood, vol. 114, (no. 22), pp. 3031, 2009-11-20. | Journal Article
 
Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results
Benson, DonBenson, DonHofmeister, Craig CHofmeister, Craig CPadmanabhan, SwaminathanPadmanabhan, SwaminathanAbonour, RafatAbonour, RafatSuvannasankha, AttayaSuvannasankha, AttayaMita, AlainMita, AlainSquiban, PatrickSquiban, PatrickSmith, Megan KSmith, Megan KBakan, Courtney EBakan, Courtney EMarzetto, MarcMarzetto, MarcAndre, PascaleAndre, PascaleTollier, JeromeTollier, JeromeCaligiuri, Michael ACaligiuri, Michael AFarag, Sherif and Farag, Sherif
Blood, vol. 114, (no. 22), pp. 2880, 2009-11-20. | Journal Article
 
Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Suvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifO'Bryant, Robin AO'Bryant, Robin AWood, Lisa LWood, Lisa LAbonour, Rafat and Abonour, Rafat
Blood, vol. 114, (no. 22), pp. 2882, 2009-11-20. | Journal Article
 
Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
Farag, SherifFarag, SherifWood, Lisa LWood, Lisa LSchwartz, Jennifer ESchwartz, Jennifer ESrivastava, ShivaniSrivastava, ShivaniNelson, Robert PNelson, Robert PRobertson, MichaelRobertson, MichaelAbonour, RafatAbonour, RafatSayar, HamidSayar, HamidCripe, Larry D and Cripe, Larry D
Blood, vol. 114, (no. 22), pp. 198, 2009-11-20. | Journal Article
 
T.133. Post-Engraftment Anti-CD25 for the Prevention of Acute Graft-versus-host disease (GVHD) after Minimally Intensive Cyclophosphamide/Fludarabine (Cy/Flu) Conditioning and Hematopoietic Cell Transplantation
Nelson, RobertNelson, RobertNelson, R.Robertson, MichaelRobertson, M.Robertson, MichaelSchwartz, J.Schwartz, JenniferSchwartz, JenniferCornetta, KennethCornetta, KennethCornetta, Kenneth GSrivastava, ShivaniSrivastava, ShivaniSrivastava, ShivaniKiel, PatrickKiel, PatrickKiel, P.Yu, MenggangYu, MenggangYu, MenggangWood, LisaWood, L.Wood, LisaBaute, JohnBaute, J.Baute, JohnO'Bryant, R.O'Bryant, RobinO'Bryant, RobinCripe, L.Cripe, LarryCripe, LarryAbonour, RafatAbonour, R.Abonour, RafatFarag, SherifFarag, S. and Farag, Sherif
Clinical Immunology, vol. 131, pp. S91, 2009. | Journal Article
 
The Role of the Antiapoptotic Protein c-FLIP in Multiple Myeloma
Crean, Colin DCrean, Colin DCrean, Colin DZhang, GenglinZhang, GenglinZhang, GenglinVanRyckeghem, Lauren BVanRyckeghem, Lauren BVanRyckeghem, Lauren BHanenberg, HelmutHanenberg, HelmutHanenberg, HelmutFarag, SherifFarag, SherifFarag, SherifAbonour, RafatAbonour, RafatAbonour, RafatSuvannasankha, AttayaSuvannasankha, Attaya and Suvannasankha, Attaya
Blood, vol. 114, (no. 22), pp. 1966, 2009-11-20. | Journal Article
2008
Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaCrean, ColinCrean, Colin DCrean, ColinShanmugam, RajasubramaniamShanmugam, RajasubramaniamShanmugam, RajasubramaniamFarag, SherifFarag, Sherif SFarag, SherifAbonour, RafatAbonour, RafatAbonour, RafatBoswell, H.Boswell, HScottBoswell, H.Nakshatri, HarikrishnaNakshatri, Harikrishna and Nakshatri, Harikrishna
Clinical Cancer Research, vol. 14, (no. 6), pp. 1814-1822, 2008. | Journal Article
 
A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma
Wolf, Jeffrey LeeSiegel, DavidMatous, JeffreyLonial, SagarGoldschmidt, HartmutSchmitt, StefanVij, RaviDe Malgalhaes-Silverman, MargaridaAbonour, RafatJalaluddin, MuhammadLi, MarthaHazell, KatharineBourquelot, Priscille MMateos, Maria-VictoriaAnderson, Kenneth CSpencer, AndrewHarousseau, Jean-Luc and BladeĢ, Joan
Blood, vol. 112, (no. 11), pp. 2774, 2008-11-16. | Journal Article
 
Effect of Venous Thrombotic Events on Overall Survival in Multiple Myeloma: Analysis of Thrombotic Events Occurring in E4A03A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma, a Trial Coordinated by the Eastern Cooperative Oncology Group (ECOG)
Jacobus, SusannaKumar, ShajiCallander, Natalie ScottAbonour, RafatFonseca, RafaelSiegel, DavidGreipp, Philip and Rajkumar, S. Vincent
Blood, vol. 112, (no. 11), pp. 1740, 2008-11-16. | Journal Article
 
Gastrointestinal Plasmacytoma Presenting as Gastrointestinal Bleeding
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatCummings, Oscar WCummings, Oscar WCummings, Oscar WLiangpunsakul, SuthatLiangpunsakul, Suthat and Liangpunsakul, Suthat
Clinical Lymphoma & Myeloma, vol. 8, (no. 5), pp. 311, October 2008. | Journal Article
 
Response Duration with Initial Therapy Is a Major Predictor of Overall Survival in Multiple Myeloma: Analysis from Multiple Phase III ECOG Clinical Trials
Kumar, ShajiZhang, LijunDispenzieri, AngelaLonial, SagarAbonour, RafatHeffner, LeonardCallander, Natalie ScottSiegel, DavidGertz, MorieKyle, RobertGreipp, Philip R and Rajkumar, S. Vincent
Blood, vol. 112, (no. 11), pp. 5129, 2008-11-16. | Journal Article
 
Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells
Zhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongWang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingChen, LiChen, LiChen, LiChen, LiLiang, JingLiang, JingLiang, JingLiang, JingSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatFarag, Sherif SFarag, Sherif SFarag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 5171, 2008-11-16. | Journal Article
 
The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo, and Shows Synergistic Activity in Combination with Lenalidomide
Wang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingSinn, Anthony LSinn, Anthony LSinn, Anthony LSinn, Anthony LSinn, Anthony LSinn, Anthony LSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaCrean, Colin DCrean, Colin DCrean, Colin DCrean, Colin DCrean, Colin DCrean, Colin DChen, LiChen, LiChen, LiChen, LiChen, LiChen, LiZhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongLiang, JingLiang, JingLiang, JingLiang, JingLiang, JingLiang, JingZhang, GenglinZhang, GenglinZhang, GenglinZhang, GenglinZhang, GenglinZhang, GenglinPollok, Karen EPollok, Karen EPollok, Karen EPollok, Karen EPollok, Karen EPollok, Karen EAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatSidor, CarolynSidor, CarolynSidor, CarolynSidor, CarolynSidor, CarolynSidor, CarolynBray, Mark RBray, Mark RBray, Mark RBray, Mark RBray, Mark RBray, Mark RFarag, Sherif SFarag, Sherif SFarag, Sherif SFarag, Sherif SFarag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 3660, 2008-11-16. | Journal Article
2007
93. Enhanced functional recovery of cryopreserved peripheral blood stem cells using a novel cell washing device
Woods, Erik JWoods, Erik JByers, Michael AByers, Michael APollok, Karen EPollok, Karen EAbonour, RafatAbonour, RafatCritser, John KCritser, John KMa, HewuMa, HewuGao, Dayong and Gao, Dayong
Cryobiology, vol. 55, (no. 3), pp. 355, 2007. | Journal Article
 
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings
Stadtmauer, Edward AStadtmauer, Edward AStadtmauer, Edward ALonial, SagarLonial, SagarLonial, SagarVesole, David HVesole, David HVesole, David HAbonour, RafatAbonour, RafatAbonour, RafatAlsina, MelissaAlsina, MelissaAlsina, MelissaBadros, AshrafBadros, AshrafBadros, AshrafComenzo, RaymondComenzo, RaymondComenzo, RaymondDurie, BrianDurie, BrianDurie, BrianGiralt, SergioGiralt, SergioGiralt, SergioHussein, MohamadHussein, MohamadHussein, MohamadJakubowiak, AndrzejJakubowiak, AndrzejJakubowiak, AndrzejMehta, JayeshMehta, JayeshMehta, JayeshNiesvizky, RubenNiesvizky, RubenNiesvizky, RubenOrlowski, RobertOrlowski, RobertOrlowski, RobertSiegel, DavidSiegel, DavidSiegel, DavidSinghal, SeemaSinghal, SeemaSinghal, SeemaVescio, RobertVescio, RobertVescio, RobertWang, MichaelWang, MichaelWang, MichaelZangari, MaurizioZangari, MaurizioZangari, MaurizioMunshi, Nikhil CMunshi, Nikhil C and Munshi, Nikhil C
Clinical advances in hematology & oncology : H&O, vol. 5, (no. 10 Suppl 15), pp. 7, 2007-Oct. | Journal Article
 
A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group
Rajkumar, S. VincentJacobus, SusannaCallander, NatalieFonseca, RafaelVesole, DavidWilliams, MichaelAbonour, RafatSiegel, David and Greipp, Philip
Blood, vol. 110, (no. 11), pp. 74, 2007-11-16. | Journal Article
 
Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21
Suvannasankha, AttayaSuvannasankha, AttayaFausel, ChristopherFausel, ChristopherJuliar, BethJuliar, Beth EYiannoutsos, Constantin TYiannoutsos, ConstantinFisher, William BFisher, WilliamAnsari, RafatAnsari, Rafat HWood, Lisa LWood, LisaSmith, Gina GSmith, GinaCripe, Larry DCripe, LarryAbonour, Rafat and Abonour, Rafat
Oncologist, vol. 12, (no. 1), pp. 99-106, 2007. | Journal Article